ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bearishCelltrion Inc
08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
bullishSK Inc
14 Jul 2018 10:38

SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications

SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...

Logo
654 Views
Share
13 Jul 2018 01:56

Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications

This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...

Logo
813 Views
Share
12 Jul 2018 17:44

Samsung Biologics: Regulators Crack Down On Its Accounting

After the market close today, the Korean regulators (Financial Services Commission) made a major negative announcement on Samsung Biologics Co.,...

Logo
469 Views
Share
30 Jun 2018 18:40

Korea Stock Market Monthly Recap #26 (June 2018)

"Sell in May and Go Away" continued its trend in the Korea Stock Market in June. Since end of April, KOSPI is down 7.5% in terms of Won and it is...

Logo
180 Views
Share
x